Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method and application of millet embryo extract

A production method and embryonic technology, applied in the field of millet embryonic element, can solve the problems of unrealistic, allergies, pollution bacteria, etc., and achieve the effect of convenient drug use and prolonging life

Inactive Publication Date: 2017-05-10
谢培增 +3
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

); In 1998, American scientists succeeded in culturing human embryonic stem cells in vitro. Since then, scholars at home and abroad have used different stem cells to treat different diseases. Both heterogeneous (sheep) and heterogeneous have serious complications such as immune rejection, allergy, and systemic infection caused by contaminated bacteria during in vitro culture.
[0009] Since then, scholars at home and abroad have used different stem cells to treat different diseases, and the short-term therapeutic effect can be confirmed. However, there are currently the following problems: whether it is sheep placenta or human embryonic stem cells, because they are heterogeneous (sheep) and heterogeneous cells, patients will not be able to use them after using them. There are serious complications such as immune rejection, allergy, and systemic infection caused by contaminated bacteria during in vitro culture.
Therefore, it is unrealistic to directly use plant stem cells to repair the damage of human tissue cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of millet embryo extract
  • Preparation method and application of millet embryo extract
  • Preparation method and application of millet embryo extract

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] The present embodiment provides a kind of preparation method of millet embryonic element

[0039] 1. Obtain millet embryo tissue

[0040] 1.1 Selected millet species:

[0041] Requirements for selecting rice seeds: preferably from high-yielding, healthy and disease-free rice seeds of the current year. In this example, a high-quality, high-yielding, disease-resistant hybrid millet combination (variety) was obtained from the millet seed base in Wuchuan County, Inner Mongolia, China. According to different production requirements, the number of rice seeds varies, and 10, 100, and 500 kilograms can be used as a base. According to the test and experimental dosage, 500 kilograms of millet can be used as a base.

[0042] 1.2 Proper breeding of seedlings:

[0043] Dry the seeds 8 days before sowing, soak them in 1% lime water for 2 to 3 days after drying for 1 to 2 days, to facilitate disinfection and germination, and promote seed germination. Then wash with clean water and...

Embodiment 2

[0222] MEF Therapeutic Animal Experiments

[0223] Choose large and small white mice, rabbits, dogs, and monkeys to make models of different wounds and 15 different diseases, and apply control and REF intervention to treat more than 500 different animal experiments successively. The models include the following 9 representative diseases of each system: (1) Canine craniocerebral injury model; (2) monkey cerebral ischemia model; (3) canine chronic obstructive pulmonary disease model; (4) canine gastric and duodenal ulcer model; (5) canine liver cirrhosis (cirrhosis) Model; (6) canine acute myocardial infarction dynamic type; (7) canine diabetes model; (8) canine renal failure model; (9) canine burn model (REF treatment of animal experiments is an innovation of the present invention); (10) other models . Animal model standards in each group are unified according to experimental requirements; curative effect standards are in accordance with relevant disease curative effect standa...

Embodiment 3

[0229] Clinical Application Trial of MEF

[0230] 1. Diseases treated by MEF:

[0231] Embryotherapy is suitable for diseases of various systems, including sub-health, promoting normal growth and development of children, immune system deficiency diseases, infectious diseases, tumors (various benign and malignant tumors), nervous system diseases, respiratory system diseases, digestive system diseases, Cardiovascular system diseases, endocrine system diseases, skeletal and muscular system diseases, blood system diseases, urinary system diseases, reproductive system diseases, sexual function diseases, peripheral vascular diseases, skin diseases, difficult diseases of eyes, ears, nose, pharynx and larynx , anti-aging and beauty, etc.

[0232] 2. Number of diseases treated by MEF:

[0233] Various diseases and anti-aging treatment methods have treated more than 2,000 patients.

[0234] 3. MEF treatment plan:

[0235] ①Selection of MEF: Choose MEF products in different dosage fo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of a millet embryo extract. The preparation method comprises the following steps: conducting cell wall-breaking treatment on millet embryo stem cells, removing impurities and conducting centrifuging, so that the pluripotent millet embryo extract is obtained. The method also discloses the millet embryo extract prepared by the preparation method and an application of the millet embryo extract. The pluripotent millet embryo extract, which is isolated from the pluripotent millet embryo stem cells, can achieve effects of a human embryo extract, namely keeping activities of various cells in a human body and prolonging service life of working cells; repairing injured cells and recovering cell functions; activating dormant cells in the human body and supplementing effective working cells; protecting attenuation of autologous stem cells and promoting generation of the stem cells; and exciting differentiation of autologous dormant stem cells to generate new cells to substitute for dead cells, so that a function of recovering organs is achieved.

Description

technical field [0001] The invention relates to the technical fields of pharmaceuticals, food and cosmetics, in particular to a millet embryonic element, and specifically relates to a preparation method and application of the millet embryonic element. Background technique [0002] Although there are thousands of human diseases, there is only one real disease, which is cell disease. If there is a problem with the cell metabolism of any organ, and the cell death reaches a certain level, then this organ will get sick, which is the main cause of cell failure. There are two aspects: one is the lack of cell nutrition and oxygen supply, and the other is that the metabolic waste cannot be discharged in time, which leads to cell poisoning. Now the understanding of the disease is only the manifestation of the disease, not the real cause, and the treatment is mostly symptomatic. (such as the treatment of pain, fever, etc.) or allopathic treatment (resection of tumors, radiotherapy, che...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P1/04A61P1/16A61P3/10A61P9/00A61P9/10A61P13/12A61K8/9794A61Q19/08A61Q19/00
CPCA61K36/899A61K8/97A61K2800/805A61Q19/00A61Q19/08
Inventor 谢培增沈会强刘江谢成沈明阳郑晓云
Owner 谢培增
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products